Evithé Biotechnology developed technologies to cue plants to produce new compounds. Our research has lead to the development of novel, patented products that address inflammation and promote longevity including herbal supplements (market ready), medical foods (registration ready), botanical drugs (phase 2 ready) and pharmaceutical drugs (Phase 1 ready).
Evithé Biotechnology focuses on a solution for the number 1 cause of disability and death worldwide - Chronic inflammation. We do this by addressing its pathogenesis (root cause) by addressing a range of related disease targets that promote longevity. Our vision of the future is healthier, longer lives.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Wellington, Nz
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.evithe.com
- Keywords
- Pty Ltd.
- HQ
- Wellington
Evithé Biotechnology Questions
Evithé Biotechnology's website is http://www.evithe.com
Evithé Biotechnology's LinkedIn profile is https://nz.linkedin.com/company/evithebio
Evithé Biotechnology has
5 employees.
View email and phone details for 5
employees at Evithé Biotechnology.
Evithé Biotechnology's industry is
Pharmaceutical Manufacturing
Evithé Biotechnology's top competitors are
Bioviros,
Ezz Life Science Holdings Asx:ezz,
Cambium Bio,
Lachesis Biosciences,
Blinklab Limited (Asx:bb1),
Global Pharma Solutions,
Arotec Diagnostics Limited,
Cad-It Australia Pty Ltd,
Bontia Bio,
Atticus Medical.
Evithé Biotechnology's categories are Pharmaceutical Manufacturing
Evithé Biotechnology's founding year is 2017
